News from the world
15
May
US FDA official details top observations from QMSR inspections
The top observations identified in Form 483 reports from inspections conducted under the recently implemented Quality Management System Regulation (QMSR) include risk management, outsourcing and purchasing, and complaint handling and feedback....[RAPS]
17
Jul
Inside Pharma’s Push for More Resilient Supply Chains
Industry leaders from Samsung Biologics and Fujifilm Biotechnologies discuss how regional manufacturing,...
17
Jul
US FDA CDER plans new guidance on AI, electronic safety report submissions, and more
The US Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) has...
16
Jul
EU DG SANTE and EMA sign Working Arrangement with New Zealand Ministry of Health
DG SANTE and the European Medicines Agency (EMA) have signed a Working Arrangement with New Zealand Ministry...
15
Jul
Riforma farmaceutica. Via libera della Commissione Sanità del Senato
Le poche modifiche approvate non cambiano l'impianto della riforma. L’articolo 3 a...
latest news
09 Jun
Pharma, Italia leader, ma debole nei principi attivi, produzione da potenziare
04 Jun
AIFA - Indicazioni sulla modalità di comunicazione dei periodi di chiusura estiva dei siti di produzione di sostanze attive
27 May
Generics drugmaker Sandoz calls for EU to probe alleged China dumping
22 May
Min. Salute - Strategia nazionale sulla salute e sicurezza sul lavoro, approvata in Conferenza Stato-Regioni
22 May
Testo unico farmaceutica, i lavori entrano nel vivo: a breve l’esame dei 302 emendamenti
18 May
AIFA Sistema informatico Workflow Officine Materie Prime - Ulteriore Aggiornamento tecnico 18 maggio 2026
15 May
US FDA’s New AI-Informed Inspection Pilot and What It Means for Industry
15 May
EU Regulators discuss new pharma legislation, AI, and more